You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pomalyst

Showing 1 - 25 of 94
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pomalyst® Capsules Under Actual Use in All Treated With Pomalyst

Completed
  • Multiple Myeloma
    • No City Provided, New Jersey
    • +1 more
    Jun 30, 2022

    Bioequivalence Study Trial in Chennai (Pomalidomide 4 MG Oral Capsule)

    Not yet recruiting
    • Bioequivalence Study
    • Pomalidomide 4 MG Oral Capsule
    • Chennai, Tamil Nadu, India
      Azidus Laboratories
    Sep 22, 2023

    Multiple Myeloma, Relapse Multiple Myeloma Trial in Chicago (Belantamab mafodotin, Carfilzomib, Pomalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Relapse Multiple Myeloma
    • Belantamab mafodotin
    • +3 more
    • Chicago, Illinois
      University of Chicago Medicine Comprehensive Cancer Center
    Mar 23, 2023

    Evaluation of POMALYST® Treatment of Multiple Myeloma in Korea

    Recruiting
    • Multiple Myeloma
    • POMALYST® (Pomalidomide)
    • Ansan, Korea, Republic of
    • +32 more
    Aug 17, 2022

    High Grade Squamous Intra-epithelial Lesion (HSIL) Trial in Darlinghurst (Pomalidomide 2 MG Oral Capsule [Pomalyst])

    Active, not recruiting
    • High Grade Squamous Intra-epithelial Lesion (HSIL)
    • Pomalidomide 2 MG Oral Capsule [Pomalyst]
    • Darlinghurst, New South Wales, Australia
      St Vincent's Hospital
    Mar 28, 2022

    Multiple Myeloma Trial in Lanzhou (Pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Lanzhou, Gansu, China
      The First Hospital of Lanzhou University
    Jul 9, 2022

    Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)

    Not yet recruiting
    • Relapsed Refractory Multiple Myeloma
    • (no location specified)
    Feb 6, 2023

    Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Ixazomib, Pomalidomide, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Multiple Myeloma in Relapse
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Apr 13, 2022

    Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Mar 3, 2022

    Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

    Recruiting
    • Relapsed Refractory Multiple Myeloma
    • Abemaciclib, dexamethasone, ixazomib, pomalidomide
    • +7 more
    • Phoenix, Arizona
    • +16 more
    Sep 9, 2021

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Portland (Carfilzomib, Isatuximab, Pomalidomide)

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jun 14, 2022

    Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

    Recruiting
    • Multiple Myeloma
    • Hackensack, New Jersey
      John Theurer Cancer Center
    Jun 10, 2022

    Multiple Myeloma, Amyloidosis Trial in Toronto (Lenalidomide, Pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Amyloidosis
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Nov 26, 2021

    Multiple Myeloma Trial (Daratumumab, Cyclophosphamide, Pomalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 8, 2021

    AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

    Not yet recruiting
    • AL Amyloidosis
    • Venetoclax Oral Tablet, 200 mg
    • +9 more
    • New York, New York
      New York Presbyterian Hospital/Columbia University Irving Medica
    Jul 11, 2022

    Myeloma Trial in La Jolla, Orange, Sacramento (Clarithromycin, Dexamethasone, Ixazomib Citrate)

    Active, not recruiting
    • Myeloma
    • La Jolla, California
    • +2 more
    Mar 14, 2022

    Multiple Myeloma Trial in Milwaukee (Isatuximab (for run-in portion), Isatuximab (for expansion), Pomalidomide)

    Recruiting
    • Multiple Myeloma
    • Isatuximab (for run-in portion)
    • +4 more
    • Milwaukee, Wisconsin
      Froedtert Hospital & the Medical College of Wisconsin
    Feb 18, 2022

    Relapsed/Refractory Multiple Myeloma Trial in La Jolla (Ixazomib, Pomalidomide, Dexamethasone)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • La Jolla, California
      UCSD Moores Cancer Center
    Mar 7, 2022

    Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

    Recruiting
    • Multiple Myeloma
    • Athens, Greece
    • +8 more
    Nov 30, 2022

    Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,

    Active, not recruiting
    Has Results
    • Refractory Plasma Cell Myeloma
    • Recurrent Plasma Cell Myeloma
    • ixazomib citrate
    • +2 more
    • Scottsdale, Arizona
    • +4 more
    Mar 28, 2022

    Multiple Myeloma Trial (Pembrolizumab, Pomalidomide, Dexamethasone)

    Terminated
    Has Results
    • Multiple Myeloma
    • Pembrolizumab
    • +2 more
    • (no location specified)
    Sep 13, 2021

    Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Biospecimen Collection
    • +3 more
    • Baltimore, Maryland
    • +2 more
    Jan 19, 2023

    Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Carfilzomib)

    Terminated
    • Multiple Myeloma
    • Encinitas, California
    • +5 more
    Mar 15, 2022

    Plasma Cell Myeloma Trial in Atlanta (Carfilzomib, Dexamethasone, Pomalidomide)

    Recruiting
    • Plasma Cell Myeloma
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Oct 5, 2021

    Multiple Myeloma Trial in Washington, Hackensack (Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG)

    Recruiting
    • Multiple Myeloma
    • Selinexor 60 MG
    • +6 more
    • Washington, District of Columbia
    • +1 more
    Feb 3, 2022